Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia.

Marcin Basiak Marcin Hachuła Michal Kosowski Bogusław Okopień

Published in: Journal of clinical medicine (2022)

Our findings indicate that treatment with PCSK9 inhibitors has a multipotential effect on fibrinolysis and coagulation in patients with isolated hypercholesterolemia and that this medication may have some future benefits in patients who are statin-intolerant or contraindicated to statin use.

Keyphrases

low density lipoprotein
end stage renal disease
cardiovascular disease
coronary artery disease
ejection fraction
newly diagnosed
cardiovascular events
chronic kidney disease
prognostic factors
peritoneal dialysis
type diabetes
current status
patient reported outcomes
combination therapy